Cursos

Actividades Académicas
Atrás

XX International School of Pharmacology "Teófilo Hernando". Retina Degeneration: Frontier Therapies To Prevent Blindness

Información General

Información General

Procedimiento para realizar la matrícula

Programa del curso

Código
65EN
Horas
30
Fecha
17 Jul 2023
21 Jul 2023
Precio
157,5 € Tarifa C
Tipo
Escuela
Temática
Biología y Biomedicina
ECTS
2,5

Sede donde se gestiona

Santander

Lugar de impartición

Santander - Península de la Magdalena (Rector Ernest Lluch)

Dirección

Antonio G. García
Universidad Autónoma de Madrid

Nicolás Cuenca
Universidad de Alicante, Spain

Secretaría

Luis Gandía Juan
Universidad Autónoma de Madrid

ORGANIZADO EN COLABORACIÓN CON


ORGANIZADO EN COLABORACIÓN CON

Descripción de la actividad

The International Pharmacology School “Teófilo Hernando” was initiated in 1996, in the frame of the summer courses of UIMP. At that time, Rector José Luis García Delgado invited professor Antonio G. García (Universidad Autónoma de Madrid) to organise this School. The School was named after Teófilo Hernando, a Spanish MD/PhD pharmacologist who was trained under Oswald Schmiedeberg at Strassbourg, the first formal Pharmacology School where many pharmacologists throughout the word were trained at the end of the XIX century and the beginning of the XX century and then developed the subject of basic and clinical pharmacology in their own countries. Teófilo Hernando introduced pharmacology as an independent teaching and science subject at the Universidad Complutense de Madrid, along the first three decades of the XX century this academic matter soon spread out to several Spanish universities by pharmacologists trained under professor Hernando. He trained numerous other disciples that extended the subject to many other Spanish universities along the XX century. The format of a UIMP’s School ( “Escuela”) is based in the critical analysis in the frontier of knowledge of a given scientific topic, along a week ( Monday to Friday) by scientists and students of all over the world. Two sessions are delivered in the morning by invited scientists, lasting each one two hours, with vivid discussions. In the afternoon, PhD students and postdocs present their ongoing scientific work as short oral communications. Emphasis is always made in the identification of new biological drug targets that illuminate the design, synthesis and development of new medicines to treat human diseases.